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ABSTRACT
This study assessed the reproducibility and epidemiological concordance of double-enzyme fluorescent
amplified fragment length polymorphism (fAFLP) analysis for genotyping of Legionella pneumophila
serogroup (sg) 1. fAFLP fragment analysis was performed on three different sequencing platforms (one
gel- and two capillary-based) in different laboratories with a well-characterised set of 50 strains of
L. pneumophila sg 1. fAFLP data were analysed with the Pearson correlation similarity coefficient, using a
range of parameters, and dendrogram outputs were converted to arbitrary types after selection of a
specified percentage similarity threshold. The results obtained were compared with those obtained by
the standard non-fluorescent AFLP method and were found to be broadly concordant. Using optimised
settings for each fAFLP method to analyse the panel of 50 strains, epidemiological concordance (E) and
reproducibility (R) values of 1.00 were obtained, and the number of types ranged from nine to 15,
compared with E = 1.00 and R = 1.00, with 16 types, for the non-fluorescent AFLP protocol. The study
demonstrated the potential of fAFLP for typing strains of L. pneumophila sg 1 on all three platforms;
however, inter-platform comparison of fAFLP data was not achieved. fAFLP analysis may have a role in
the fingerprinting of multiple isolates during Legionella outbreak investigations, but further work is
required before type designations and identification libraries can be developed.
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INTRODUCTION
The requirement for a genotypic method for the
differentiation of Legionella pneumophila isolates is
well-documented [1,2]. L. pneumophila causes the
vast majority of cases of legionellosis worldwide,
and most of these isolates belong to serogroup
(sg) 1 [3]. Thus, in order to confirm or refute an
epidemiological relationship between clinical
cases and suspected environmental sources, dif-
ferentiation below the level of serogroup and
monoclonal antibody type is usually required.
Many factors influence the choice of technique
employed by laboratories for this purpose, e.g.,
labour, time, cost, access to equipment and level
of expertise. These techniques can be divided into
two main groups, termed ‘fingerprinting’ and
‘epidemiological typing’. While many definitions
of these terms may be found in the literature, the
term ‘fingerprinting’ can be defined in this con-
text as a genotypic method suitable for use on all
the isolates being evaluated, at one time, by a
single laboratory, and would include highly
discriminatory, but poorly reproducible, tech-
niques, e.g., PCR using an arbitrary primer (AP-
PCR) [4]. In contrast, true epidemiological typing
allows the allocation of an isolate to a previously
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defined type, making possible the construction of
on-line identification libraries [5]. Such libraries
are suitable for long-term epidemiological stud-
ies, and allow remote comparisons without the
need for the transfer of isolates between laborat-
ories.
One genotypic method, amplified fragment
length polymorphism (AFLP) analysis, has been
standardised for epidemiological typing of
L. pneumophila and is used widely by members
of the European Working Group for Legionella
Infections (EWGLI; http://www.ewgli.org). This
method uses a non-fluorescent single-enzyme
(PstI) approach, with AFLP types being allocated
based on the mean band sizes of the profiles
obtained following agarose gel electrophoresis
with a defined protocol.
Fluorescent AFLP (fAFLP) has been reported to
be a reproducible and highly discriminatory
method suitable for typing [6,7]. However, this
approach requires considerable technical manipu-
lation in both the optimisation and completion of
reactions, as well as in the data analysis. There-
fore, it may not be sufficiently robust or trans-
portable to allow true epidemiological typing.
Although various platforms capable of fluorescent
detection of labelled DNA fragments are now
available commercially, there are few data regard-
ing the comparative performance of these plat-
forms for epidemiological typing, including for
L. pneumophila [8]. The present study compared
the results obtained with a double-enzyme fAFLP
protocol performed on three different platforms
(one gel- and two capillary-based) in different
laboratories, using a well-characterised set of 50
strains of L. pneumophila sg 1. The aims of the study
were: (1) to assess the reproducibility (R) and
epidemiological concordance (E) of the fAFLP
protocol on each platform; and (2) to assess the
suitability of fAFLP for fingerprinting, or typing,
of L. pneumophila sg 1. To facilitate these assess-
ments, results were compared with those obtained
from a previous study using the standardised non-
fluorescent method [9].
MATERIALS AND METHODS
Participants
Participants from three institutions (Institute of Environmental
Medicine and Hospital Epidemiology, Freiburg, Germany;
Health Protection Agency, Centre for Infections, London, UK;
National Institute for Infectious Diseases, Rome, Italy) took
part in the study. Each of these centres acts as a local or
national reference laboratory for Legionella infections. The
study was coordinated at the Health Protection Agency,
Respiratory and Systemic Infection Laboratory, Centre for
Infections, London, UK.
Bacterial strains
A collection of 50 L. pneumophila sg 1 isolates from nine
European countries was used. The characteristics of these
isolates have been described previously [4,9]. The collection
comprised one reproducibility panel of 20 isolates and one
epidemiologically related panel of 30 isolates (Table 1). The
reproducibility panel comprised ten duplicate isolates, and the
epidemiologically related panel comprised nine epidemiolog-
ically related sets and one additional set comprising variants of
the same strain. All isolates were designated by a unique
European Union Legionella culture collection number (EUL no.)
[9]. Replicate cultures were prepared on Buffered Charcoal
Yeast Extract (BCYE) agar (Oxoid, Basingstoke, UK) slopes,
were randomly allocated a study code number, and were
distributed to the participating laboratories by courier. Fol-
lowing receipt, the isolates were cultured by inoculation on to
BCYE agar (Oxoid) plates and incubated for 2–4 days at 37C
in either CO2 5% v ⁄v or a moist environment.
Genomic DNA preparation
DNA was prepared after harvesting fresh bacterial growth,
either by the method of Ausubel et al. [10], as described by
Valsangiacomo et al. [11], or with the Nucleon BACC2 Kit
(Amersham Pharmacia Biotech, Little Chalfont, UK), according
to the manufacturer’s recommendations, including treatment
with RNase A. Genomic DNA preparations from both methods
were resuspended in 1 · TE buffer (10 mM Tris-HCl, 1 mM
EDTA, pH 8.0) and the DNA concentration was determined
spectrophotometrically by measuring the absorbance at 260 nm.
Each centre examined the coded isolates by fAFLP analysis,
using the protocols described below, on one of three platforms:
(1) an ALF Express DNA Sequencer (Amersham Pharmacia
Biotech); (2) a CEQ 8000 DNA Analysis System (Beckman
Coulter, Fullerton, CA, USA); or (3) an ABI 3100 Analysis
System (Applied Biosystems, Foster City, CA, USA), referred
to hereafter as ALF, CEQ and ABI, respectively. A standard-
ised fAFLP method was devised (see below), based on the
method described by Arnold et al. [6], and was distributed by
the coordinating centre. Any deviation from this method was
recorded and reported to the coordinating centre. Evaluation
of the data using the fAFLP protocol on each of the platforms
was based on the Consensus Guidelines of the European Study
Group on Epidemiological Markers [12] as described previ-
ously [4,9]. For each platform, dendrogram outputs were
converted to arbitrary ‘types’ by selecting a percentage
similarity threshold at (or above) which strains were consid-
ered to be indistinguishable (i.e., belonging to the same type).
The reproducibility (R) was defined as the ability of the
method to correctly identify epidemiologically related isolates
as the same type. The epidemiological concordance (E) was
defined as the number of epidemiologically related strains
found to be indistinguishable, divided by the total number of
such sets in the study. Intra-run variation and inter-run
variation were determined with L. pneumophila strain EUL
no. 137 on the ALF and CEQ, or with Escherichia coli W3110
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(Applied Biosystems) on the ABI. Variation was calculated by
analysing results from the same strains from the same run and
different runs, and then taking the percentage similarity
threshold at (or above) which all the profiles clustered together
into the same type. Variation was expressed as 100% minus
this percentage threshold. The R and E values, as well as the
number of types obtained, were compared with data from
previous studies using a non-fluorescent AFLP method [9,13].
fAFLP protocols
At the start of this study, the complete genomic sequence of
L. pneumophila was not available. Therefore, the choice of
restriction endonucleases and primers for fAFLP analysis was
based on those recommended for AFLP analysis of organisms
with a mol% G + C content of 38–47 [14,15], since L. pneumo-
phila had a reported mol% G + C of 39 [16]. The original AFLP
method used radioisotopic end-labelling of the primers [14,15],
but the present study used fluorescent labelling and fragment
analysis protocols recommended by the manufacturer of each
of the three platforms described above. Where required, all
reaction mixes were made up to volume with PCR-grade water
(Promega, Southampton, UK; Carlo Erba Reagenti, Milano,
Italy; or DeltaSelect GmbH, Pfullingen, Germany).
fAFLP using the ALF Express
The initial restriction endonuclease digestion was performed
at 37C for 2 h in a total volume of 20 lL. Each reaction mix
contained c. 500 ng of genomic DNA, 5 U of MseI (New
England Biolabs, Beverly, MA, USA), 0.2 lL of bovine serum
albumin (BSA) (New England Biolabs) 10 mg ⁄mL, 1.0 lL of
Table 1. Reproducibility and epidemiologically related panels, showing details of replicates, variants and epidemiolog-
ically related sets of clinical and environmental isolates of Legionella pneumophila sg 1
EUL no. Sender designation Study code no. Country of origin Characteristics and source of isolate
Reproducibility panel
001 IBS-2 22 Switzerland Clinical isolate
001 IBS-2 33 Duplicate of above
002 IBS-25 41 Switzerland Clinical isolate
002 IBS-25 47 Duplicate of above
019 94 ⁄ 51727 3 Scotland Clinical isolate
019 94 ⁄ 51727 34 Duplicate of above
031 L51 38 France Clinical isolate
031 L51 7 Duplicate of above
036 1 40 Italy Clinical isolate
036 1 46 Duplicate of above
051 16140 ⁄ 95 35 Spain Clinical isolate
051 16140 ⁄ 95 36 Duplicate of above
086 R270 39 Denmark Clinical isolate
086 R270 16 Duplicate of above
096 L810 12 Denmark Clinical isolate
096 L810 23 Duplicate of above
101 LD10 ⁄ 94 17 Sweden Clinical isolate
101 LD10 ⁄ 94 8 Duplicate of above
121 R4-Augsburg1 37 Germany Clinical isolate
121 R4-Augsburg1 45 Duplicate of above
Epidemiologically related panel
073 LC3832a 9 England & Wales Clinical isolates from same patient;
each isolate is a single colony picked from
the primary isolation plate
078 LC3832b 18
079 LC3832c 4
071 LC3868 24 England & Wales Clinical isolates from same patient;
isolated from sputum by direct culture076 LC3869 13
077 LC3870 10 Isolated from sputum via amoebal co-culture
Isolated from faeces by direct culture
048 006 ⁄ 96 25 Spain Clinical isolates from same patient
056 17 ⁄ 96 6
040 5 19 Italy Clinical isolate
047 12 26 Related environmental isolate
124 LC462 14 England & Wales Clinical isolates from same patient
125 LC463 27
126 ML64 28 England & Wales Clinical isolates from the Stafford District
127 ML65 15 General Hospital outbreak
128 ML66 1
129 LC436 29 England & Wales Clinical isolates from hotel outbreak in Croatia
130 LRU88 52
131 LC536 30 England & Wales Clinical isolates from the BBC outbreak,
132 LC537 31 London
133 LC539 42
134 LC540 48
135 Corby RA ⁄LC4404 43 England & Wales Corby strain variant after seven passes in amoebae
136 Corby CA ⁄LC4405 49 Corby strain variant after 100 passes on MH
137 Corby CAC ⁄LC4406 50 Corby strain variant after 100 passes on BCYE
138 Corby Rif ⁄LC4407 5 Corby strain variant from a rifampicin mutant
139 Corby 3 ⁄ 1- ⁄LC4408 2 Corby strain variant from a mAb3 ⁄ 1– mutant
140 1956X ⁄ 96 11 Spain Clinical isolate from Madrid outbreak, Spain
141 2099X ⁄ 96 32 Clinical isolate
142 208 ⁄ 96 44 Related environmental isolate
143 209 ⁄ 96 51 Related environmental isolate
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DNase-free RNase A (Sigma, Poole, UK) 10 mg ⁄mL and
1 · MseI buffer (New England Biolabs). Following incubation,
the second digestion was achieved by adding 2 lL of 0.5 M
Tris-HCl, pH 7.2, 2.5 lL of 0.5 M NaCl and 5 U of EcoRI (New
England Biolabs) to the initial mix (final volume, 25 lL),
followed by incubation for a further 2 h at 37C. Mixes were
then incubated at 65C for 10 min to inactivate the endonuc-
leases, and then kept on ice prior to ligation. Ligation mixes
comprised 25 lL of the double-digest mix, 5 pmol of EcoRI
adaptor (EcoRI-1, 5¢-CTCGTAGACTGCGTACC-3¢; EcoRI-2, 5¢-
AATTGGTACGCAGTC-3¢), 50 pmol of MseI adaptor (MseI-1,
5¢-GACGATGAGTCCTGAG-3¢; MseI-2, 5¢-CTACTCAGGACT-
CAT-3¢), 40 U of T4 DNA ligase and 1 · T4 ligase buffer (New
England BioLabs). Reaction mixes were incubated at 12C for
18 h, heated at 65C for 10 min and then stored below )20C
until required. This restriction–ligation mix was used as
template DNA (2.5 lL) in the PCRs.
Amplification was performed in a reaction volume of 25 lL.
Each mix contained 2.5 mM MgCl2, 10 mM Tris-HCl (pH 8.3),
50 mM KCl, 200 lM each deoxynucleotide, 16.6 pmol of
labelled EcoRI-C primer (5¢-GACTGCGTACCAATTCC-3¢),
100 pmol of MseI-A primer (5¢-GATGAGTCCTGAGTAAA-3¢)
and 0.65 U of Taq DNA polymerase (Invitrogen, Paisley, UK).
The EcoRI-C primer was labelled at the 5¢-terminus with Cy-5
(MWG Biotech, Ebersburg, Germany). Amplification was
performed in a DNA engine PTC-200 (MJ Research; Bio-Rad,
Waltham, MA, USA) with denaturation at 94C for 2 min,
followed by 30 cycles of 20 s at 94C, 30 s at the annealing
temperature (66C to 56C), 2 min at 72C, and a final
extension at 60C for 30 min. Touchdown PCR was used; i.e.,
the initial annealing temperature of 66C (for 30 s) was
decreased by 1C for each of the next nine cycles; an annealing
temperature of 56C was used for the final 20 cycles.
Detection of fluorescently-labelled products was by auto-
mated laser fluorescence analysis. Amplification products
(1 lL) were denatured and then separated on a denaturing
polyacrylamide gel in the ALF Express. Gels were prepared
using polyacrylamide 5.5% (Long-Ranger; FMC Bioproducts,
Rockland, ME, USA) containing 6 M urea in 0.6 · TBE
(0.53 mM Tris-borate, pH 8.3, 1.2 mM EDTA). Samples were
loaded together with 50-bp and 300-bp internal standards
(Amersham Pharmacia Biotech). Electrophoresis conditions
comprised 800 V at 55C for 480 min using 0.6 · TBE buffer. A
50-bp ladder (Amersham Pharmacia Biotech) was used as an
external standard. Gel images were converted to tagged
information file format (TIFF) files with the Alf2tiff software
tool (Amersham Pharmacia Biotech) and processed with
GelCompar II or BioNumerics software v. 3.5 (Applied Maths,
St-Martens-Latem, Belgium). Fragment sizes were calculated
following normalisation using the internal and external stand-
ards. Data sets were analysed with a background subtraction
disk size of 3% without least square filtering. Group analysis
was performed with the Pearson correlation coefficient and the
unweighted pair-group method with averages (UPGMA)
clustering method. An optimisation setting of 0.02% was
used, and only fragments between 50 and 300 nucleotides (nt)
in size were included in the analyses.
fAFLP using the Beckman CEQ 8000 DNA Analysis System
The fAFLP protocol was followed as described above, except
that the EcoRI-C primer was labelled at the 5¢-terminus with
D4-PA (Invitrogen) for detection on the Beckman CEQ 8000.
Amplification products (0.5–1.0 lL) were mixed with 40 lL of
sample loading solution (SLS, Beckman Coulter) containing a
600-nt marker (Beckman Coulter) 0.5% (v ⁄v), and were then
separated using the FRAG-4 program. Densitometric curves
were imported into BioNumerics using the ABI conversion
filter. Settings for background subtraction were a disk size of
20%, a least square filtering cut-off of < 0.04%, and a power of
2. Analysis was performed with the Pearson correlation
coefficient and the UPGMA clustering method, with an
optimisation setting of 0.11. Only fragments within the size
range 60–640 nt were included.
fAFLP using the Applied Biosystems 3100
fAFLP was performed with the AFLP Microbial Fingerprinting
kit (Applied Biosystems), according to the recommendations
of the manufacturer. Reference DNA from E. coli W3110
(Applied Biosystems) was used as an internal control through-
out the analysis. Briefly, 10 ng of purified Legionella DNA was
restricted simultaneously with EcoRI and MseI (New England
Biolabs) and ligated to the adaptor–linker primers with T4
DNA ligase (New England Biolabs) for 2 h at 37C in a final
volume of 11 lL. After addition of 150 lL of nuclease-free
water, 4 lL of the diluted ligation mix was amplified with the
EcoRI and MseI core primers (Applied Biosystems) in a final
volume of 20 lL. Non-selective pre-amplification was per-
formed at 72C for 2 min, followed by 20 cycles of 94C for
20 s, 56C for 30 s and 72C for 2 min. The presence of
multiple-sized amplification products was checked by electro-
phoresis on agarose 1.5% w ⁄v gels in 1 · TBE buffer. After
addition of 150 lL of nuclease-free water, 1.5 lL of the diluted
pre-selective amplification product was used as template for
selective amplification. PCR was performed in 10-lL volumes
containing 1.5 lL of template DNA, 0.5 lL of NED-labelled
EcoRI-C selective primer (1 mM), 0.5 lL of MseI-A selective
primer (5 mM), and 7.5 lL of AFLP Core Amplification Mix
(all reagents from Applied Biosystems). Touchdown PCR
cycling conditions were used for amplification, as described
above, using a GeneAmp 9600 thermocycler (Perkin-Elmer,
Emeryville, CA, USA). Five microlitres of the labelled PCR mix
were mixed with 12 lL of Ultrapure Formamide and 0.5 lL of
Genescan Rox500 internal lane standard (Applied Biosystems)
in a Microamp optical 96-well reaction plate. Separation and
detection of AFLP fragments were performed with a model
3100 capillary electrophoresis system equipped with a 36-cm
capillary loaded with the POP-4 polymer (Applied Biosys-
tems). Samples were injected for 22 s at 1 kV and separated for
108 min at 100 mA. Densitometric curves were imported into
BioNumerics as described above. Settings for background
subtraction were a disk size of 10%, a least square filtering cut-
off of < 2.95%, and a power of 2. Analysis was performed with
the Pearson correlation coefficient and the UPGMA clustering
method, and an optimisation setting value of zero. Only data
within the size range > 35 nt to < 500 nt were included.
Data analysis
Gel images or densitometric traces were exported from each
platform and analysed with either GelCompar II (Applied
Maths) or BioNumerics (Applied Maths) software. Only peaks
within the range of the molecular size marker used were
included in the initial analyses. The curve-based Pearson
correlation similarity coefficient was used with the UPGMA
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clustering method, using the range of parameters described
above. Dendrogram outputs were converted to arbitrary types
after selection of a specified percentage similarity threshold at
(or above) which strains were considered to belong to the same
type. The optimal percentage threshold for each method is
given above. All analyses were undertaken before the code
was broken. All data were subjected to visual analysis by the
coordinating centre, to determine the presence of any reaction
‘failures’, which were scored as ‘fail’. Repeat testing of any
such isolates was performed, together with a number of
related and unrelated isolates, to allow final scoring of the
same maximum number of sets. Results were compared with
those obtained by the EWGLI non-fluorescent AFLP method
for the same panel of isolates [9].
RESULTS
Fig. 1 shows examples of the results obtained
with each of the three platforms. Although each of
the isolates in the study was typeable by all three
of the fAFLP protocols, there were two ‘failures’
in individual sample runs, resulting in ‘fail’
scores. Thus, the results for the initial run of
study code no. 16 (EUL no. 086) and study code
no. 31 (EUL no. 132) could not be evaluated
following fAFLP analysis on the CEQ. Duplicate
or related sets containing such failures were
excluded from the analyses. Upon retesting of
these two isolates, study code no. 16 (EUL no. 086)
clustered at > 85% with its replicate, i.e., study
code no. 39 (EUL no. 086), while study code no. 31
(EUL no. 132) clustered at > 85% with the isolates
in its epidemiologically linked set (study code
nos. 30, 42 and 48). These values were above the
threshold used to assign types on this platform;
therefore, these isolates were scored subsequently
as a match for the reproducibility value and
epidemiological concordance values.
The reproducibility (R) value is related to the
percentage similarity threshold (defined above).
Optimal percentage similarity threshold values
were different for each platform. Values of
R = 1.00 were achieved at thresholds of 90%,
85% and 79% for the ALF express, CEQ and ABI,
respectively. Using these thresholds, an epidemi-
ological concordance (E) value of 1.0 was
achieved on all three platforms, with the number
of distinct types obtained being 12 (ALF), nine
(CEQ) and 15 (ABI). Increasing the thresholds
reduced the reproducibility value and ⁄ or the
epidemiological concordance values for each
platform (data not shown). Intra- and inter-gel
variation values (calculated from within and
between gel data from a control strain) were 7%
(100% to 93%), 3% (100% to 97%) and 2% (100%
to 98%) for the ABI, CEQ and vertical gel-based
ALF express system, respectively.
Evidence for epidemiological typing
Use of comparable ‘type’ designations by all
three centres provided evidence for true
(a)
(b)
(c)
Fig. 1. Examples of normalised
patterns obtained following fAFLP
analysis of Legionella pneumophila sg
1 isolates from the reproducibility
and epidemiologically related
panels. Study code nos. 8 and 17 are
replicates of the same strain. Study
codes nos. 4, 9 and 18 are a set of
epidemiologically related strains. (a)
ALF Express (gel). (b) ABI Prism
3100 (capillary). (c) CEQ 8000
(capillary). nt, nucleotide.
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epidemiological typing, as distinct from finger-
printing. Comparable type designations were
assigned by all three centres for two sets of
isolates included in the epidemiologically related
panel (Table 2). The first set (designated type C,
A or G on the ALF, CEQ or ABI platforms,
respectively) comprised three isolates from the
same patient obtained by different culture meth-
ods (study code nos. 10, 13 and 24), and two
clinical isolates from a hotel outbreak in Croatia
(study code nos. 29 and 52). The second set
(designated type H, D or L) comprised three
isolates derived from single colonies on a pri-
mary isolation plate from the same patient
(study code nos. 4, 9 and 18), and three isolates
from a well-characterised hospital outbreak in
Stafford, UK (study code nos. 1, 15 and 28).
Complete concordance between the three plat-
forms was not observed.
Comparison with non-fluorescent AFLP method
Of the three fAFLP platforms, the ALF express
platform correlated most closely with the EWGLI
AFLP method in terms of comparable type des-
ignations; for example, EWGLI AFLP 013 London
was scored as type H on three of four occasions,
and 009 London was scored as type A on both of
two occasions. Interestingly, one of the two sets
where comparable type designations were used
by all three fAFLP platforms (C, A or G) was
subdivided into two EWGLI AFLP types, 010
London and 014 London. The CEQ was the only
platform to subdivide the EWGLI type 013 Lon-
don into two types (D and I).
The discriminatory index of fAFLP was not
addressed specifically in this study because of the
relatively small sample size. However, a compar-
ison of the number of types obtained by each of
the fAFLP platforms with the maximum number
of types obtained by the EWGLI AFLP method
(n = 16) was made in order to provide an estimate
of their relative discriminatory power. The ABI
platform appeared to be the most discriminatory
approach, dividing the 20 sets into 15 types,
followed by the ALF express (12 types) and the
CEQ platform (nine types).
DISCUSSION
Since its initial description, AFLP analysis has
been used as a fingerprinting method for human
forensic and paternity testing [17], for monitoring
inheritance of genetic markers in plants [18], and
in studies of microorganisms [19–21]. Microbial
applications of AFLP include investigations of
genomic relatedness and diversity, genotyping,
characterisation of outbreak strains, and polypha-
sic taxonomy. EWGLI members have previously
Table 2. Results of fAFLP analysis of Legionella pneumo-
phila sg 1 using three platforms, compared with a previ-
ously described non-fluorescent AFLP method [10],
showing correlation coefficient, percentage similarity
threshold, type designation and number of types; sets of
strains designated as having the same type by all three
fAFLP platforms are in bold type
EUL no.
Study
code
no.
EWGLIa
AFLP
Dice
(90%)
ALF
Express
Pearson
(90%)
CEQ
8000
Pearson
(85%)
ABI
Prism 3100
Pearson
(79%)
001 22 001 Lugano E E B
001 33 001 Lugano E E B
002 41 002 Lugano I C B
002 47 002 Lugano I C B
031 38 004 Lyon F B D
031 7 004 Lyon F B D
019 3 003 Glasgow H D M
019 34 003 Glasgow H D M
036 40 005 Rome D A F
036 46 005 Rome D A F
051 35 002 Lugano I C H
051 36 002 Lugano I C H
040 19 012 Rome L H N
047 26 012 Rome L H N
048 25 011 Madrid G B K
056 6 011 Madrid G B K
071 24 010 London C A G
076 13 010 London C A G
077 10 010 London C A G
073 9 013 London H D L
078 18 013 London H D L
079 4 013 London H D L
086 39 006 Copenhagen F B E
086 16 006 Copenhagen F Bb E
096 12 007 Copenhagen I C A
096 23 007 Copenhagen I C A
101 17 008 Stockholm K A C
101 8 008 Stockholm K A C
121 37 009 London A G A
121 45 009 London A G A
124 14 009 London A G O
125 27 009 London A G O
126 28 013 London H D L
127 15 013 London H D L
128 1 013 London H D L
129 29 014 London C A G
130 52 014 London C A G
131 30 013 London H I L
132 31 013 London H Ib L
133 42 013 London H I L
134 48 013 London H I L
135 43 015 Dresden J C I
136 49 015 Dresden J C I
137 50 015 Dresden J C I
138 5 015 Dresden J C I
139 2 015 Dresden J C I
140 11 016 Madrid B F J
141 32 016 Madrid B F J
142 44 016 Madrid B F J
143 51 016 Madrid B F J
No. of types 16 12 9 15
aEuropean Working Group for Legionella Infections.
bInitial result not evaluable; result of repeated sample is shown.
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investigated single-enzyme non-fluorescent AFLP
as a typing tool for L. pneumophila sg 1 [4,9,13]. This
method was adopted as the first internationally
agreed typing method for L. pneumophila sg 1, and
is currently used by many centres in Europe and
Australia [22]. However, proficiency panel evalu-
ation of this method revealed problems in achiev-
ing optimal results, associated with user-defined
band scoring, which is, by its nature, subjective.
fAFLP has been reported to be reproducible,
more discriminatory and capable of higher
throughput than other molecular typing methods
[7,23]. After initial optimisation, this method
should also be more amenable to automated
analysis using software, and should require less
user intervention in, for example, the scoring and
assignment of types. However, there are few
studies on the use of fAFLP as an epidemiological
typing tool, and to our knowledge, no reports on
its use for typing isolates of L. pneumophila sg 1.
The present study investigated the performance
of three fAFLP platforms, two capillary and one
vertical gel-based, for genotyping isolates of
L. pneumophila sg 1. Performance was assessed
by comparison of reproducibility and epidemio-
logical concordance scores using a coded panel of
isolates.
The results demonstrated that all three plat-
forms were capable of achieving high reproduc-
ibility (R = 1.0) and epidemiological concordance
(E = 1.0) scores. The assignment of isolates to the
same epidemiological type by all three methods
also demonstrated the potential of this approach
as an epidemiological typing system. One of the
aims of the study was to compare the perform-
ance of the three platforms, so variation in the
procedures was kept to a minimum wherever
possible. Two centres used a commercial kit for
DNA extraction and one used a published organic
extraction method. Both methods have been
shown previously to yield high molecular size
DNA from Legionella. Two centres used the same
supplier for the unlabelled oligonucleotides. Two
centres used thermocyclers manufactured by MJ
Research and the other used a thermocycler
manufactured by Perkin-Elmer. The most signifi-
cant variation in the fAFLP protocols was the
inclusion of a non-selective pre-amplification step
in the ABI protocol with EcoRI and MseI core
primers. Other variations included the method of
DNA extraction, the fluorescent labels, the inclu-
sion of a non-selective amplification step (one
method), the molecular size markers, the method
of separation (capillary or gel), and the settings
used for analysis. Some of these variations (such
as the method of DNA extraction) have been
shown previously to have no apparent effect on
AFLP profiles visualised on agarose gels [9].
Other sources of variation (e.g., fluorescent labels
and the method of separation) are associated with
the intrinsic differences between platforms. It is
noteworthy that, although intra- and inter-run
variations obtained with a control strain were
between 2% and 7%, values obtained with the
reproducibility panel suggest that the variation
can be much higher (10–21%). These data illus-
trate clearly the requirement to evaluate a range
of isolates to determine the level of variation in
such systems. One factor that was found to have a
significant effect on the performance of fAFLP
was the amount of sample loaded on to the gel;
for example, one centre tried loading volumes of
3 lL and 7 lL, and the larger volume was found
to be sub-optimal on the ABI platform (data not
shown). The critical differences between the three
platforms were in the different analysis settings
required. Although the different platforms might
be expected to produce similar results, cross-
platform analyses could not be performed, as all
the profiles from the same platform clustered
together (data not shown).
The study illustrated the potential of the fAFLP
methodology to function as a true epidemiolog-
ical genotyping tool for L. pneumophila sg 1, as
judged by good reproducibility and epidemiolog-
ical concordance scores, as well as the ability to
assign strains to the same type in a coded trial.
However, meaningful comparison of profiles
between the platforms studied was restricted.
Apart from the differences noted above, the most
likely explanation for differences between plat-
forms is the mobility of the labelled fragments
through the gel matrix and their subsequent
normalisation. To assess the performance of the
fAFLP method more accurately, the fragment
sizes could be determined in silico, using the
L. pneumophila genome sequence [24], with sub-
sequent comparison of fragment sizes in terms of
base-pairs. Further studies to determine the dis-
crimatory index of such systems would also need
to be performed.
Comparison of the fAFLP data with data
obtained by the non-fluorescent method
revealed broad concordance between these two
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techniques. This was despite major differences, in
particular, the inclusion of single- vs. double-
enzyme AFLP, band sizes, and the correlation
coefficients used for analyses. Complete concor-
dance between the non-fluorescent method and
any of the fluorescent methods was not observed.
However, both AFLP and fAFLP show potential
for epidemiological typing of L. pneumophila sg 1.
In conclusion, the double-enzyme fAFLP pro-
tocol used in the present study appeared to be
applicable to different detection platforms. Care-
ful optimisation of reaction conditions and ana-
lysis are required, but once achieved can provide
excellent results. Comparing data between plat-
forms remains difficult, but designation of
profiles to defined types could allow the devel-
opment of a typing system using densitometric
curves or profiles based on fragment sizes in base-
pairs. The fAFLP method also allows for the
potential characterisation of many isolates or
colonies from an outbreak investigation at a
relatively low cost, particularly when using the
multiple capillary platforms. These methods
could therefore be used to screen large numbers
of L. pneumophila isolates in an outbreak situation,
prior to further investigation of indistinguishable
isolates by other genotyping methods, including
sequence-based typing [25]. fAFLP may also be
applicable to the investigation of legionellosis
caused by non-sg 1 isolates of L. pneumophila or
other non-pneumophila species of Legionella.
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